Integrum AB (OSTO:INTEG B) Common Stock : kr1.30 Mil (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Integrum AB Common Stock?

Integrum AB's quarterly common stock stayed the same from Jul. 2023 (kr1.30 Mil) to Oct. 2023 (kr1.30 Mil) and stayed the same from Oct. 2023 (kr1.30 Mil) to Jan. 2024 (kr1.30 Mil).

Integrum AB's annual common stock increased from Apr. 2021 (kr1.11 Mil) to Apr. 2022 (kr1.28 Mil) and increased from Apr. 2022 (kr1.28 Mil) to Apr. 2023 (kr1.29 Mil).

Integrum AB Common Stock Historical Data

The historical data trend for Integrum AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB Common Stock Chart

Integrum AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Common Stock

Get a 7-Day Free Trial

0.88

1.06

1.11

1.28

1.29

Integrum AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Common Stock	Get a 7-Day Free Trial															1.28	1.29	1.30	1.30	1.30

Integrum AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Integrum AB (OSTO:INTEG B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

6Y1:Germany

Address

Krokslatts Fabriker 50, Molndal, SWE, SE-431 37

Website

http://www.integrum.se

Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB (OSTO:INTEG B) Headlines

No Headlines